Page 16 - Mobile Opera News Today

The Federal Trade Commission has voted unanimously to launch an inquiry into pharmacy benefit managers, requiring the six largest managers to supply records pertaining to their business practices, according to an agency press release.

SAN DIEGO — Although percutaneous liver biopsy is still the “gold standard,” advances in techniques and increased use of endoscopic ultrasound-guided biopsy may soon change that dynamic, according to a debate at Digestive Disease Week 2022. “There are several advantages to [endoscopic ultrasound (EUS)-guided liver biopsy], not the least of which is patient comfort,”

Patients with knee osteoarthritis receiving antihistamines demonstrate less structural disease progression, compared with those who did not take antihistamines, over 2 years, according to data presented at the EULAR 2022 Congress.

CHARLOTTE, N.C. — More than 50% of patients who came to an academic health care center with cardiac or neurological conditions also were found to have sleep apnea or other sleep disturbances, according to a study presented at SLEEP 2022. Anecdotally, these conditions are known to appear concomitantly, according to study authors.

SAN FRANCISCO — Treatment with imatinib resulted in a sustained clinical benefit after 90 days in hospitalized patients with hypoxemic COVID-19, according to results of the CounterCOVID study.At the American Thoracic Society International Conference, Job R. Schippers, MD-PhD candidate for pulmonary medicine at Amsterdam University Medical Center, presented long-term clinical outcomes at 90

I often hear, “Hey, I know you from Twitter!” as I turn on my heels to identify the source. A variation of this exclamation has become commonplace at scientific conferences. Particularly in a time characterized by so much distance, the use of social media can be helpful for connecting with new areas of scholarship, fellow scientists and the people most affected by the work we do.

Although the development and use of biomarkers in liver transplantation has progressed in recent years, challenges and limitations remain, according to presenters at the American Transplant Congress 2022. Thomas D. Schiano, MD, professor of medicine and liver diseases at Mount Sinai in New York, told attendees that among transplant patients, biomarkers should monitor short- and long-term

Patients with psoriatic arthritis treated with bimekizumab demonstrated improvements across joint and skin parameters compared with placebo, according to Phase 3 clinical trial data presented at the EULAR 2022 Congress.“I am delighted to be able to present these very exciting Phase 3 data from the BE COMPLETE study of this inhibitor of both IL-17A and -F,” Joseph F. Merola, MD, of

The FDA has approved rituximab-arrx, in combination with methotrexate, in adult patients with moderate or severely active rheumatoid arthritis who have had inadequate responses to one or more TNF agonist therapies. Rituximab-arrx (Riabni, Amgen), a biosimilar to rituximab (Rituxan, Genentech) was previously approved for indications including non-Hodgkin’s lymphoma, chronic lymphocytic

Compared with living donors aged 50 to 70 years, donor age older than 70 years may be a negative predictor of kidney transplant and graft survival, according to a presentation at the American Transplant Congress.“I set out to see if the data and outcomes of a national cohort met my anecdotal findings that living kidney donor transplants from donors [older than] 70 years don’t perform